Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome

IntroductionVitamin D deficiency is common, but no data have been reported on vitamin D levels in light chain (AL) amyloidosis.Patients and MethodsIn this exploratory study, stored serum samples from 173 patients with newly diagnosed AL amyloidosis were analyzed for vitamin studies which included 25...

Full description

Bibliographic Details
Main Authors: Eli Muchtar, Matthew T. Drake, Nelson Leung, Angela Dispenzieri, Martha Q. Lacy, Francis K. Buadi, David Dingli, Suzanne R. Hayman, Prashant Kapoor, Yi Lisa Hwa, Amie Fonder, Miriam Hobbs, Wilson Gonsalves, Taxiarchis V. Kourelis, Rahma Warsame, Stephen Russell, Ronald S. Go, Moritz Binder, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar, Morie A. Gertz
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.891712/full
_version_ 1811333650953797632
author Eli Muchtar
Matthew T. Drake
Matthew T. Drake
Nelson Leung
Nelson Leung
Angela Dispenzieri
Martha Q. Lacy
Francis K. Buadi
David Dingli
Suzanne R. Hayman
Prashant Kapoor
Yi Lisa Hwa
Amie Fonder
Miriam Hobbs
Wilson Gonsalves
Taxiarchis V. Kourelis
Rahma Warsame
Stephen Russell
Ronald S. Go
Moritz Binder
Robert A. Kyle
S. Vincent Rajkumar
Shaji K. Kumar
Morie A. Gertz
author_facet Eli Muchtar
Matthew T. Drake
Matthew T. Drake
Nelson Leung
Nelson Leung
Angela Dispenzieri
Martha Q. Lacy
Francis K. Buadi
David Dingli
Suzanne R. Hayman
Prashant Kapoor
Yi Lisa Hwa
Amie Fonder
Miriam Hobbs
Wilson Gonsalves
Taxiarchis V. Kourelis
Rahma Warsame
Stephen Russell
Ronald S. Go
Moritz Binder
Robert A. Kyle
S. Vincent Rajkumar
Shaji K. Kumar
Morie A. Gertz
author_sort Eli Muchtar
collection DOAJ
description IntroductionVitamin D deficiency is common, but no data have been reported on vitamin D levels in light chain (AL) amyloidosis.Patients and MethodsIn this exploratory study, stored serum samples from 173 patients with newly diagnosed AL amyloidosis were analyzed for vitamin studies which included 25-hydroxyvitamin D [25(OH)D], 1,25-dihydroxyvitamin D [1,25(OH)2D] and vitamin D binding protein (DBP). Measurements were made by liquid chromatography-tandem mass spectrometry. Kidney survival and overall survival (OS) were assessed in association to vitamin D status.ResultsCardiac and kidney involvement occurred in 69% and 63% of patients, respectively. 25(OH)D deficiency (<20 ng/mL) was seen in 56.6% of the patients and was notably found among patients with heavy proteinuria (96%), hypoalbuminemia (84.3%) and morbidly obese patients (68.3%). Heavy proteinuria (>5 gr/24-h) and vitamin D supplementation were independent predictors of 25(OH)D level on nominal multivariate regression analysis. 1,25(0H)2D deficiency was noted in 37.6% of patients and was independently associated with low eGFR and hypoalbuminemia. Progression to ESRD occurred in 23.7% of evaluable patients. Patients who progressed to ESRD had lower serum 25(OH)D and 1,25(OH)2D levels compared to those who did not progress to ESRD. On a multivariate analysis, severe 25(OH)D deficiency was an independent predictor of progression to ESRD as was renal stage, while 1,25(OH)2D deficiency was not.ConclusionsHypovitaminosis D is common in AL amyloidosis, particularly among patients with heavy proteinuria. Severe 25(OH)D deficiency at time of diagnosis predicts progression to ESRD.
first_indexed 2024-04-13T16:56:10Z
format Article
id doaj.art-ba524f74cc864fed94a7e7acb5a37633
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-13T16:56:10Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-ba524f74cc864fed94a7e7acb5a376332022-12-22T02:38:48ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-06-011310.3389/fendo.2022.891712891712Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal OutcomeEli Muchtar0Matthew T. Drake1Matthew T. Drake2Nelson Leung3Nelson Leung4Angela Dispenzieri5Martha Q. Lacy6Francis K. Buadi7David Dingli8Suzanne R. Hayman9Prashant Kapoor10Yi Lisa Hwa11Amie Fonder12Miriam Hobbs13Wilson Gonsalves14Taxiarchis V. Kourelis15Rahma Warsame16Stephen Russell17Ronald S. Go18Moritz Binder19Robert A. Kyle20S. Vincent Rajkumar21Shaji K. Kumar22Morie A. Gertz23Division of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDepartment of Endocrinology and Kogod Center of Aging, Mayo Clinic College of Medicine, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesDivision of Hematology, Mayo Clinic, Rochester, MN, United StatesIntroductionVitamin D deficiency is common, but no data have been reported on vitamin D levels in light chain (AL) amyloidosis.Patients and MethodsIn this exploratory study, stored serum samples from 173 patients with newly diagnosed AL amyloidosis were analyzed for vitamin studies which included 25-hydroxyvitamin D [25(OH)D], 1,25-dihydroxyvitamin D [1,25(OH)2D] and vitamin D binding protein (DBP). Measurements were made by liquid chromatography-tandem mass spectrometry. Kidney survival and overall survival (OS) were assessed in association to vitamin D status.ResultsCardiac and kidney involvement occurred in 69% and 63% of patients, respectively. 25(OH)D deficiency (<20 ng/mL) was seen in 56.6% of the patients and was notably found among patients with heavy proteinuria (96%), hypoalbuminemia (84.3%) and morbidly obese patients (68.3%). Heavy proteinuria (>5 gr/24-h) and vitamin D supplementation were independent predictors of 25(OH)D level on nominal multivariate regression analysis. 1,25(0H)2D deficiency was noted in 37.6% of patients and was independently associated with low eGFR and hypoalbuminemia. Progression to ESRD occurred in 23.7% of evaluable patients. Patients who progressed to ESRD had lower serum 25(OH)D and 1,25(OH)2D levels compared to those who did not progress to ESRD. On a multivariate analysis, severe 25(OH)D deficiency was an independent predictor of progression to ESRD as was renal stage, while 1,25(OH)2D deficiency was not.ConclusionsHypovitaminosis D is common in AL amyloidosis, particularly among patients with heavy proteinuria. Severe 25(OH)D deficiency at time of diagnosis predicts progression to ESRD.https://www.frontiersin.org/articles/10.3389/fendo.2022.891712/fullnephrotic syndromedialysisproteinuriakidney survivalvitamin D
spellingShingle Eli Muchtar
Matthew T. Drake
Matthew T. Drake
Nelson Leung
Nelson Leung
Angela Dispenzieri
Martha Q. Lacy
Francis K. Buadi
David Dingli
Suzanne R. Hayman
Prashant Kapoor
Yi Lisa Hwa
Amie Fonder
Miriam Hobbs
Wilson Gonsalves
Taxiarchis V. Kourelis
Rahma Warsame
Stephen Russell
Ronald S. Go
Moritz Binder
Robert A. Kyle
S. Vincent Rajkumar
Shaji K. Kumar
Morie A. Gertz
Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome
Frontiers in Endocrinology
nephrotic syndrome
dialysis
proteinuria
kidney survival
vitamin D
title Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome
title_full Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome
title_fullStr Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome
title_full_unstemmed Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome
title_short Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome
title_sort hypovitaminosis d is prevalent in patients with renal al amyloidosis and associated with renal outcome
topic nephrotic syndrome
dialysis
proteinuria
kidney survival
vitamin D
url https://www.frontiersin.org/articles/10.3389/fendo.2022.891712/full
work_keys_str_mv AT elimuchtar hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT matthewtdrake hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT matthewtdrake hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT nelsonleung hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT nelsonleung hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT angeladispenzieri hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT marthaqlacy hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT franciskbuadi hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT daviddingli hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT suzannerhayman hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT prashantkapoor hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT yilisahwa hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT amiefonder hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT miriamhobbs hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT wilsongonsalves hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT taxiarchisvkourelis hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT rahmawarsame hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT stephenrussell hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT ronaldsgo hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT moritzbinder hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT robertakyle hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT svincentrajkumar hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT shajikkumar hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome
AT morieagertz hypovitaminosisdisprevalentinpatientswithrenalalamyloidosisandassociatedwithrenaloutcome